Carrie Melvin's Insider Trades & SAST Disclosures

Carrie Melvin's most recent trade in Viridian Therapeutics Inc was a trade of 54,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 8, 2023.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Viridian Therapeutics Inc
Carrie Melvin COO Grant, award, or other acquisition of securities at price $ 0.00 per share. 08 Feb 2023 54,000 54,000 - - Stock Option (Right to Buy)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades